176 related articles for article (PubMed ID: 20346222)
1. The value of radiotherapy in patients with T1 and T2 breast cancer with one to three positive nodes after modified radical mastectomy.
Qiao XY; Song YZ; Geng CZ; Gao W; Li CX; Zhou ZG
Chin J Cancer; 2010 Apr; 29(4):436-40. PubMed ID: 20346222
[TBL] [Abstract][Full Text] [Related]
2. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
[TBL] [Abstract][Full Text] [Related]
3. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiotherapy in breast cancer patients: 32 years of follow-up.
Riet FG; Fayard F; Arriagada R; Santos MA; Bourgier C; Ferchiou M; Heymann S; Delaloge S; Mazouni C; Dunant A; Rivera S
Eur J Cancer; 2017 May; 76():45-51. PubMed ID: 28267657
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
[TBL] [Abstract][Full Text] [Related]
7. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
9. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
Danforth DN; Zujewski J; O'Shaughnessy J; Riseberg D; Steinberg SM; McAtee N; Noone M; Chow C; Chaudhry U; Lippman M; Jacobson J; Okunieff P; Cowan KH
Ann Surg Oncol; 1998 Mar; 5(2):150-8. PubMed ID: 9527268
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
[TBL] [Abstract][Full Text] [Related]
11. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A
Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842
[TBL] [Abstract][Full Text] [Related]
12. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
14. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
16. Partial chest wall radiation therapy for positive or close surgical margins after modified radical mastectomy for breast cancer without lymph node metastasis.
Ishibashi N; Nishimaki H; Maebayashi T; Adachi K; Sakurai K; Masuda S; Hata M; Okada M
Asia Pac J Clin Oncol; 2020 Feb; 16(1):28-33. PubMed ID: 31691502
[TBL] [Abstract][Full Text] [Related]
17. [Postmastectomy radiotherapy in moderate-and high-risk elderly breast cancer patients].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):863-6. PubMed ID: 20137354
[TBL] [Abstract][Full Text] [Related]
18. T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.
Perrucci E; Aristei C; De Angelis V; Anselmo P; Mascioni F; Gori S; Frattegiani A; Latini P
Tumori; 2004; 90(4):379-86. PubMed ID: 15510979
[TBL] [Abstract][Full Text] [Related]
19. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
20. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer.
Mayer A; Naszály A; Patyánik M; Zaránd P; Polgár I; Klinkó T
Strahlenther Onkol; 2002 Nov; 178(11):633-6. PubMed ID: 12426674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
